India emphasized that the weighted tariff it levies has come down from 17% in 2023 to 10.66%, following changes in duty ...

As the April 2 deadline for Trump’s reciprocal tariffs approaches, Indian markets brace for potential disruptions. While ...

The move follows the approval from the National Company Law Tribunal (NCLT), New Delhi Bench. With this consolidation, the ...

President Donald Trump announced upcoming tariffs on the pharmaceutical industry, without elaborating on specifics. He also ...

Earlier in February, the New Delhi bench of the National Company Law Tribunal (NCLT) approved the amalgamation of Shree Jee ...

U.S. President Donald Trump said on Friday that he would soon announce tariffs targeting the pharmaceutical industry but did ...

This discussion has become a moot point across sectors in India Inc., as promoters are looking at the next generation to not ...

US President Donald Trump said that he is open to tariff negotiations after he announces reciprocal tariffs on April 2, ...

Indian pharma companies may stand to gain market share due to the potential impact of US tariffs, according to a JPMorgan report.

The Board of Directors, in a meeting held on 25 March 2025, declared an interim dividend of Rs 25 per equity share on a face ...

India could see a loss of around USD 6 billion, or 0.16 per cent of its GDP, in exports to the US if broad tariffs of 10 per ...

An egg seller and a juice vendor in Madhya Pradesh and Uttar Pradesh were in for a huge shock when they received notices for dues worth crores from the Income Tax (I-T) department.